KEY FEATURES
| Full Name | Cholinergic Receptor, Nicotinic, Beta 2 |
|---|---|
| Synonym | CHR-NB2; CHRN-B2; EFNL3; NAChRB2; N-AChR-B2; N-AChRB2; Neuronal Acetylcholine Receptor Beta 2 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.06ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human CHRNb2 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CHRNb2. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CHRNb2 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CHRNb2, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CHRNb2. You can calculate the concentration of Human CHRNb2 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CHRNb2 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.52 | 1.23 | 3.42 | 0.48 | 1.24 | 3.2 |
| Standard deviation | 0.03 | 0.05 | 0.17 | 0.03 | 0.07 | 0.16 |
| CV(%) | 5.74 | 4.1 | 4.99 | 5.49 | 5.46 | 5.13 |
RECOVERY
The recovery of Human CHRNb2 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 85-97 | 90 |
| EDTA plasma (n=8) | 94-109 | 101 |
| Cell culture media (n=8) | 91-105 | 97 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CHRNb2 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with CHRNb2 ELISA Kits
| CHRNA4 ELISA Kit | publications with CHRNb2 and CHRNA4 |
| CHRNA2 ELISA Kit | publications with CHRNb2 and CHRNA2 |
| CHRNA7 ELISA Kit | publications with CHRNb2 and CHRNA7 |
| CHRNA5 ELISA Kit | publications with CHRNb2 and CHRNA5 |
| CHRNA3 ELISA Kit | publications with CHRNb2 and CHRNA3 |
| CHRNB3 ELISA Kit | publications with CHRNb2 and CHRNB3 |
| CHRNB4 ELISA Kit | publications with CHRNb2 and CHRNB4 |
| CHRNA6 ELISA Kit | publications with CHRNb2 and CHRNA6 |
Pathways associated with CHRNb2 ELISA Kit
| Acetylcholine Binding And Downstream Events Pathway | Acetylcholine Binding And Downstream Events Pathway |
| Activation Of Nicotinic Acetylcholine Receptors Pathway | Activation Of Nicotinic Acetylcholine Receptors Pathway |
| Cholinergic Synapse Pathway | Cholinergic Synapse Pathway |
| Highly Calcium Permeable Nicotinic Acetylcholine Receptors Pathway | Highly Calcium Permeable Nicotinic Acetylcholine Receptors Pathway |
| Highly Calcium Permeable Postsynaptic Nicotinic Acetylcholine Receptors Pathway | Highly Calcium Permeable Postsynaptic Nicotinic Acetylcholine Receptors Pathway |
| Highly Sodium Permeable Acetylcholine Nicotinic Receptors Pathway | Highly Sodium Permeable Acetylcholine Nicotinic Receptors Pathway |
| Neuroactive Ligand-receptor Interaction Pathway | Neuroactive Ligand-receptor Interaction Pathway |
| Neuronal System Pathway | Neuronal System Pathway |
| Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell Pathway | Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell Pathway |
Diseases associated with CHRNb2 ELISA Kit
| Nervous System Diseases | publications with CHRNb2 and Nervous System Diseases |
| Brain Diseases | publications with CHRNb2 and Brain Diseases |
| Epilepsy, Frontal Lobe | publications with CHRNb2 and Epilepsy, Frontal Lobe |
| Seizures | publications with CHRNb2 and Seizures |
| Sleep Disorders | publications with CHRNb2 and Sleep Disorders |
| Alzheimer Disease | publications with CHRNb2 and Alzheimer Disease |
| Neurobehavioral Manifestations | publications with CHRNb2 and Neurobehavioral Manifestations |
| Memory Disorders | publications with CHRNb2 and Memory Disorders |
| Epilepsy, Nocturnal Frontal Lobe, Type 3 | publications with CHRNb2 and Epilepsy, Nocturnal Frontal Lobe, Type 3 |
| Disease Models, Animal | publications with CHRNb2 and Disease Models, Animal |
Organs/Tissues associated with CHRNb2 ELISA Kit
| Brain | publications with CHRNb2 and Brain |
| Nerve | publications with CHRNb2 and Nerve |
| Heart | publications with CHRNb2 and Heart |
| Eye | publications with CHRNb2 and Eye |
| Muscle | publications with CHRNb2 and Muscle |
| Kidney | publications with CHRNb2 and Kidney |